Tekla Healthcare Investors Fund Year To Date Return
| XHQHX Fund | USD 17.25 0.23 1.35% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Tekla Healthcare's long-term financial health and intrinsic value.
Tekla |
Tekla Healthcare Investors Mutual Fund Year To Date Return Analysis
Tekla Healthcare's Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
More About Year To Date Return | All Equity Analysis
YTD Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.
As per the company's disclosures, Tekla Healthcare Investors has a Year To Date Return of 0.0%. This is 100.0% lower than that of the Category family and 100.0% lower than that of the Family category. The year to date return for all United States funds is 100.0% higher than that of the company.
Tekla Year To Date Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tekla Healthcare's direct or indirect competition against its Year To Date Return to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Tekla Healthcare could also be used in its relative valuation, which is a method of valuing Tekla Healthcare by comparing valuation metrics of similar companies.Tekla Healthcare is currently under evaluation in year to date return among similar funds.
Tekla Fundamentals
About Tekla Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Tekla Mutual Fund
Tekla Healthcare financial ratios help investors to determine whether Tekla Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Healthcare security.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |